| Posttranscriptional m6A editing of HIV-1 mRNAs enhances viral gene expression EM Kennedy, HP Bogerd, AVR Kornepati, D Kang, D Ghoshal, ... Cell host & microbe 19 (5), 675-685, 2016 | 399 | 2016 |
| Characterization of Staphylococcus aureus Cas9: a smaller Cas9 for all-in-one adeno-associated virus delivery and paired nickase applications AE Friedland, R Baral, P Singhal, K Loveluck, S Shen, M Sanchez, ... Genome biology 16, 1-10, 2015 | 356 | 2015 |
| Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease EM Kennedy, AVR Kornepati, M Goldstein, HP Bogerd, BC Poling, ... Journal of virology 88 (20), 11965-11972, 2014 | 350 | 2014 |
| Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR/Cas RNA-guided DNA endonuclease EM Kennedy, LC Bassit, H Mueller, AVR Kornepati, HP Bogerd, T Nie, ... Virology 476, 196-205, 2015 | 285 | 2015 |
| Programmed death ligand 1 signals in cancer cells AVR Kornepati, RK Vadlamudi, TJ Curiel Nature Reviews Cancer 22 (3), 174-189, 2022 | 263 | 2022 |
| Production of functional small interfering RNAs by an amino-terminal deletion mutant of human Dicer EM Kennedy, AW Whisnant, AVR Kornepati, JB Marshall, HP Bogerd, ... Proceedings of the National Academy of Sciences 112 (50), E6945-E6954, 2015 | 96 | 2015 |
| Targeting hepatitis B virus cccDNA using CRISPR/Cas9 EM Kennedy, AVR Kornepati, BR Cullen Antiviral research 123, 188-192, 2015 | 96 | 2015 |
| Expression of CRISPR/Cas single guide RNAs using small tRNA promoters AL Mefferd, AVR Kornepati, HP Bogerd, EM Kennedy, BR Cullen Rna 21 (9), 1683-1689, 2015 | 86 | 2015 |
| Specific induction of endogenous viral restriction factors using CRISPR/Cas-derived transcriptional activators HP Bogerd, AVR Kornepati, JB Marshall, EM Kennedy, BR Cullen Proceedings of the National Academy of Sciences 112 (52), E7249-E7256, 2015 | 73 | 2015 |
| Tumor intrinsic PD-L1 promotes DNA Repair in distinct cancers and suppresses PARP inhibitor–induced synthetic lethality AVR Kornepati, JT Boyd, CE Murray, J Saifetiarova, B de la Peña Avalos, ... Cancer research 82 (11), 2156-2170, 2022 | 44 | 2022 |
| The complementarity of DDR, nucleic acids and anti-tumour immunity AVR Kornepati, CM Rogers, P Sung, TJ Curiel Nature 619 (7970), 475-486, 2023 | 43 | 2023 |
| Bladder cancer cell‐intrinsic PD‐L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapy D Zhang, RM Reyes, E Osta, S Kari, HB Gupta, AS Padron, ... Cancer medicine 10 (6), 2137-2152, 2021 | 43 | 2021 |
| Targeting HPV16 DNA Using CRISPR/Cas Inhibits Anal Cancer Growth in Vivo DS Hsu, AVR Kornepati, W Glover, EM Kennedy, BR Cullen Future virology 13 (7), 475-482, 2018 | 39 | 2018 |
| Optimization of a multiplex CRISPR/Cas system for use as an antiviral therapeutic EM Kennedy, AVR Kornepati, AL Mefferd, JB Marshall, K Tsai, HP Bogerd, ... Methods 91, 82-86, 2015 | 31 | 2015 |
| CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation RM Reyes, Y Deng, D Zhang, N Ji, N Mukherjee, K Wheeler, HB Gupta, ... Journal for Immunotherapy of cancer 9 (4), e002051, 2021 | 17 | 2021 |
| Pharmacologic tumor PDL1 depletion with cefepime or ceftazidime promotes DNA damage and sensitivity to DNA-damaging agents C Murray, E Galvan, C Ontiveros, Y Deng, H Bai, AS Padron, ... International journal of molecular sciences 23 (9), 5129, 2022 | 9 | 2022 |
| Partial reconstitution of the RNAi response in human cells using Drosophila gene products EM Kennedy, AVR Kornepati, HP Bogerd, BR Cullen RNA 23 (2), 153-160, 2017 | 8 | 2017 |
| Pharmacological tumor PDL1 depletion with chlorambucil treats ovarian cancer and melanoma: improves antitumor immunity and renders anti-PDL1-resistant tumors anti-PDL1 … H Bai, AS Padron, Y Deng, YJ Liao, CJ Murray, C Ontiveros, SJ Kari, ... Journal for Immunotherapy of Cancer 11 (2), e004871, 2023 | 6 | 2023 |
| Publisher correction: programmed death ligand 1 signals in cancer cells AVR Kornepati, RK Vadlamudi, TJ Curiel Nature Reviews Cancer 22 (3), 190-190, 2022 | 4 | 2022 |
| Tumor cell-intrinsic programmed death protein 1 expression and induction in human cancer cell lines E Osta, HB Gupta, D Zhang, A Kornepati, CA Clark, TJ Curiel The Journal of Immunology 200 (1_Supplement), 178.33-178.33, 2018 | 4 | 2018 |
